• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Pfizer Issues Recall for 2 Lots of RELPAX americanpharmaceuticalreview
    August 19, 2019
    Pfizer is voluntarily recalling RELPAX® (eletriptan hydrobromide) 40 mg tablets, lots AR5407 and CD4565, to the Patient level. Pfizer Inc. initiated this recall because these product lots may not meet Pfizer’s in-house microbiological specification for ..
  • Pfizer recalls migraine med Relpax because of bacterial contamination fiercepharma
    August 18, 2019
    After an earlier recall of Relpax, Pfizer is again tracking down a couple of lots of the migraine headache med.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service